Literature DB >> 10450937

Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.

N Y Chew1, H K Chan.   

Abstract

PURPOSE: To study the effect of particle size, air flow and inhaler type on the dispersion of spray dried mannitol powders into aerosols.
METHODS: Mannitol powders were prepared by spray drying. The solid state properties of the powders were determined by laser diffraction, X-ray powder diffraction, scanning electron microscopy, freeze fracture, Karl Fischer titration and gas pycnometry. The powders were dispersed using Rotahaler and Dinkihalerg, connected to a multistage liquid impinger at different air flows.
RESULTS: Three crystalline mannitol powders with primary particle size (MMD) 2.7, 5.0, 7.3 microm and a similar polydispersity were obtained. The particles were spherical with a density of 1.5 g/cm3 and a moisture content of 0.4 wt.%. At an air flow of 30 L/min all the powders were poorly dispersed by both inhalers. With the Rotahaler increasing the flow (60-120 L/min) increased the fine particle fraction (FPF) in the aerosols for the 2.7 microm powder, and decreased the FPF for the 7.3 microm powder; whereas the FPF for 5.0 microm powder was unaffected. With the Dinkihaler, all the powders were near complete dispersion at > or = 60 L/min.
CONCLUSIONS: The FPF in the mannitol powder aerosols was determined by an interplay of the particle size, air flow and inhaler design.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450937     DOI: 10.1023/a:1018952203687

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.

Authors:  K J Smith; H K Chan; K F Brown
Journal:  J Aerosol Med       Date:  1998

2.  Inhalation of dry-powder mannitol increases mucociliary clearance.

Authors:  E Daviskas; S D Anderson; J D Brannan; H K Chan; S Eberl; G Bautovich
Journal:  Eur Respir J       Date:  1997-11       Impact factor: 16.671

3.  Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase).

Authors:  H K Chan; I Gonda
Journal:  J Pharm Sci       Date:  1998-05       Impact factor: 3.534

4.  A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol.

Authors:  S D Anderson; J Brannan; J Spring; N Spalding; L T Rodwell; K Chan; I Gonda; A Walsh; A R Clark
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

Authors:  A R Clark; A M Hollingworth
Journal:  J Aerosol Med       Date:  1993

6.  Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.

Authors:  H K Chan; A Clark; I Gonda; M Mumenthaler; C Hsu
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

7.  Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.

Authors:  D M Mitchell; M A Solomon; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

8.  Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Authors:  M M Clay; D Pavia; S W Clarke
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

  8 in total
  24 in total

1.  Use of solid corrugated particles to enhance powder aerosol performance.

Authors:  N Y Chew; H K Chan
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

3.  Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

4.  Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

5.  Particle aerosolisation and break-up in dry powder inhalers 1: evaluation and modelling of venturi effects for agglomerated systems.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-Kim Chan; John Crapper; Paul M Young
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

6.  How much particle surface corrugation is sufficient to improve aerosol performance of powders?

Authors:  Nora Y K Chew; Patricia Tang; Hak-Kim Chan; Judy A Raper
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

7.  Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Judy A Raper
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

Review 8.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

9.  Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Herbert Chiou
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

10.  Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.

Authors:  Tobias Wm Keil; Christoph Zimmermann; Domizia Baldassi; Friederike Adams; Wolfgang Friess; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.